CaitrionaRyanMDFAAD, MB, BCh, BAO, BMedSc, MRCPI

PubMed

• 2 citations
  Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patie...
  Caitriona Ryan, Lyn Guenther, Peter Foley, J. Weisman, Russel Burge, Gaia Gallo, Kyoungah See, M. McKean-Matthews, C.C. Bertram, Joseph F. Merola> ;Journal of the European Academy of Dermatology and Venereology. 2021 Nov 23
• 4 citations
  Obstructive Sleep Apnea in Psoriasis and Hidradenitis Suppurativa
  Aine Kelly, J Meurling, S Kirthi Jeyarajah, Caitriona Ryan, R. Hughes, J.F. Garvey, Brian Kirby> ;The British Journal of Dermatology. 2021 Jan 6
• 3 citations
  High Levels of Psychological Distress, Sleep Disturbance, and Alcohol Use Disorder in Adults With Atopic Dermatitis.
  Eimear Gilhooley, Ciara O'Grady, Darren Roche, Julie Mac Mahon, Roisin Hambly, Aine Kelly, Eilis Nic Dhonncha, Blaithin Moriarty, Maureen Connolly, B. Kirby, Anne-Mari...> ;Dermatitis. 2021 Oct 1
• 9 citations
  Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.
  N M Golbari, J. M. Van der Walt, Andrew Blauvelt, Caitriona Ryan, P.C.M. van de Kerkhof, Alexa B. Kimball> ;Journal of the European Academy of Dermatology and Venereology. 2021 Feb 1
• 18 citations
  Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial
  Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, Yves Poulin, Lynda Spelman, Russel Burge, J. Erickson, Kristin Todd, Clinton C Bertram, Caitriona Ryan> ;Acta Dermato-Venereologica. 2020 Jan 7
• 78 citations
  Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council.
  Bruce Strober, Caitriona Ryan, Peter C.M. van de Kerkhof, Joelle M. van der Walt, Alexa B. Kimball, Jonathan Barker, Andrew Blauvelt, Marc Bourcier, Andre V. E. de Car...> ;Journal of the American Academy of Dermatology. 2020 Jan 1
• 162 citations
  Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 ...
  Kristian Reich, Melinda Gooderham, Diamant Thaçi, Jeffrey J. Crowley, Caitriona Ryan, James G. Krueger, Tsen-Fang Tsai, Mary Flack, Yihua Gu, David A. Williams, Elizab...> ;Lancet. 2019 Aug 17
• 9 citations
  Genital Psoriasis: Impact on Quality of Life and Treatment Options.
  Aine Kelly, Caitriona Ryan> ;American Journal of Clinical Dermatology. 2019 Oct 1
• 36 citations
  Clinical considerations for the management of psoriasis in women.
  Alice B. Gottlieb, Caitriona Ryan, Jenny E. Murase> ;International Journal of Women's Dermatology. 2019 Apr 10
• 8 citations
  Genital psoriasis: the failure of dermatologists to identify genital involvement.
  Caitriona Ryan> ;The British Journal of Dermatology. 2019 Mar 1
• 49 citations
  Clinical Goals and Barriers to Effective Psoriasis Care.
  Bruce Strober, Joelle M. van der Walt, April W. Armstrong, Marc Bourcier, Andre V. E. de Carvalho, Edgardo Chouela, Arnon D. Cohen, Claudia de la Cruz, Charles N. Elli...> ;Dermatology and Therapy. 2019 Mar 1
• Adalimumab treatment for psoriasis - safety in numbers.
  Caitriona Ryan> ;The British Journal of Dermatology. 2019 Jan 1
• 27 citations
  Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study.
  Gil Yosipovitch, Peter Foley, Caitriona Ryan, Jennifer Clay Cather, K.A.P. Meeuwis, Russel Burge, Alison Potts Bleakman, Chen Yen Lin, William N Malatestinic, Alice B....> ;The Journal of Sexual Medicine. 2018 Nov 1
• 67 citations
  Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
  Caitriona Ryan, Alan Menter, Lyn Guenther, Andrew Blauvelt, Robert Bissonnette, K.A.P. Meeuwis, John Sullivan, Jennifer Clay Cather, Gil Yosipovitch, A.B. Gottlieb, Jo...> ;The British Journal of Dermatology. 2018 Oct 1
• 86 citations
  Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review.
  Adam R. Ford, Michael Siegel, Jerry Bagel, Kelly M. Cordoro, Amit Garg, Alice B. Gottlieb, Lawrence Green, Johann E. Gudjonsson, John Koo, Mark Lebwohl, Wilson Liao, A...> ;JAMA Dermatology. 2018 Aug 1
• 12 citations
  The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health
  Alice B. Gottlieb, Brian Kirby, Caitriona Ryan, April N. Naegeli, Russel Burge, Alison Potts Bleakman, Milena D. Anatchkova, Jennifer Clay Cather> ;Dermatology and Therapy. 2018 Mar 1
• 16 citations
  The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS)
  Alice B. Gottlieb, Brian Kirby, Caitriona Ryan, April N. Naegeli, Russel Burge, Alison Potts Bleakman, Milena D. Anatchkova, Gil Yosipovitch> ;Dermatology and Therapy. 2018 Mar 1
• 52 citations
  Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.
  Scott M. Whitlock, Clinton W. Enos, April W. Armstrong, Alice B. Gottlieb, Richard G. Langley, Mark Lebwohl, Joseph F. Merola, Caitriona Ryan, Michael P. Siegel, Jeffr...> ;Journal of the American Academy of Dermatology. 2018 Feb 1
• 23 citations
  Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.
  Caitriona Ryan, Jeffrey M. Sobell, Craig L. Leonardi, Charles Lynde, M. Karunaratne, Wendell C. Valdecantos, Barbara Hendrickson> ;American Journal of Clinical Dermatology. 2018 Jun 1
• 4 citations
  Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies.
  Evangelos J Giamarellos-Bourboulis, Jeffrey M. Sobell, Caitriona Ryan, Pierre J Wolkenstein, Ziqian Geng, Gerit Mulder> ;Wounds. 2017 Nov 1
• 27 citations
  Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study
  Jennifer Clay Cather, Caitriona Ryan, K.A.P. Meeuwis, Alison Potts Bleakman, April N. Naegeli, Emily Edson-Heredia, Jiat Ling Poon, Cate A. Jones, Ashley N. Wallace, L...> ;Dermatology and Therapy. 2017 Oct 26
• 52 citations
  Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes.
  Bobbak Mansouri, Dario Kivelevitch, Balaji Natarajan, Aditya A. Joshi, Caitriona Ryan, Katie E. Benjegerdes, Jeffrey M. Schussler, Daniel J. Rader, Muredach P. Reilly,...> ;JAMA Dermatology. 2016 Nov 1
• Identification of pharmacogenetic markers of treatment response to biologic therapies in psoriasis - is there a benefit?
  Caitriona Ryan> ;The British Journal of Dermatology. 2017 May 1
• 112 citations
  From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
  April W. Armstrong, Michael P. Siegel, Jerry Bagel, Erin E. Boh, Megan Buell, Kevin D. Cooper, Kristina Callis Duffin, Lawrence F. Eichenfield, Amit Garg, Joel M. Gelf...> ;Journal of the American Academy of Dermatology. 2017 Feb 1
• 4 citations
  Discordance between physician assessment of psoriasis and patient self-assessment: the importance of itch
  Caitriona Ryan, Alan Menter> ;The British Journal of Dermatology. 2016 Jul 1
• Join now to see all

Journal Articles

• Biologics in practice: using biologic agents in combination with methotrexate in psoriasis therapy. The Dermatologist 2014; 21: 28-31  
  Haugh I, Ryan C, Menter A., The Dermatologist, 3/2014
• Ryan C. Continuing the dialogue: the future of psoriasis.  
  Ryan C., Psoriasis Review, 12/2012
• Are drug treatments for psoriasis a cardiovascular risk? Clinical Practice 2012  
  Ryan C, Patel M, Menter A., Clinical Practice, 2012
• The use of pharmacogenomics in psoriasis. Clinical Investigation 2011  
  Ryan C, Bowcock A, Menter A., Clinical Investigation, 3/2011
• Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events—Reply [letter].  
  Ryan C, Daoud Y, Menter A., JAMA, 2011
• Neuropeptides and psoriasis.  
  Ryan C, Kirby B., G Ital Dermatol Venereol, 10/2007
• Join now to see all

Books/Book Chapters

• Psoriasis: Diagnosis and Management 
  Chapter: Recent and future developments in targeted therapy 
  Ryan C, Menter AEditors: Sterry W.Wiley-BlackwellEdition 1,2014
• Advances in Psoriasis 
  Chapter: Ustekinumab 
  Ryan C, Leonardi CEditors: Weinberg J.Springer2014
• Brenner's Online Encyclopedia of Genetics 
  Chapter: Psoriasis 
  Page 524 - 526Ryan C, Bowcock AM, Menter AEditors: Maloy S, Hughes Kelly.Academic PressEdition 2nd,2013

Abstracts/Posters

• Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
  Ryan C, Sadlier M, Patel M, Kirby B, Menter A, International Investigative Dermatology Meeting, Edinburgh, Scotland, 3/1/2013
• Systems analysis of pneumococcal vaccine response in psoriasis patients
  Obermoser G, Ryan C, Ruchaud E, Mansouri B, Patel M, Palucka K, Menter A, International Investigative Dermatology Meeting, Edinburgh, Scotland, 3/1/2013
• Systems analysis of pneumococcal vaccine response in psoriasis patients
  Obermoser G, Ryan C, Ruchaud E, Mansouri B, Patel M, Palucka K, Menter A, J Invest Dermatol, 1/1/2013
• Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
  Ryan C, Sadlier M, Patel M, Kirby B, Menter A, J Invest Dermatol, 1/1/2013
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu...
  Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, Kaplan DH, Menter A, Annual Meeting of Society of Investigative Dermatology, Phoenix, AZ, 5/1/2011
• Alterations in leukocyte subsets in the blood of psoriasis patients
  Obermoser G, Ryan C, Banchereau J, Pascual V, Chaussabel D, Menter A, Society of Investigational Dermatology Annual Meeting, Phoenix, AZ, 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu...
  Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, Kaplan DH, Menter A, J Invest Dermatol, 1/1/2011
• Alterations in leukocyte subsets in the blood of psoriasis patients
  Obermoser G, Ryan C, Banchereau J, Pascual V, Chaussabel D, Menter A, J Invest Dermatol, 1/1/2011
• The use of transcriptional profiling to evaluate psoriasis as a systemic disease
  Ryan C, Obermoser G, Banchereau R, Lemoine B, Pascual V, Banchereau J, Chaussabel D, Menter A, European Association of Dermatology and Venereology Annual Meeting; Society of Investigational Dermatology Annual Meeting, Atlanta, GA, 5/1/2010
• Clinical and genetic predictors of response to narrowband UVB in the treatment of chronic plaque psoriasis
  Ryan C, Renfro L, Collins P, Kirby B, Roger S, Br J Dermatol, 1/1/2010
• The use of transcriptional profiling to evaluate psoriasis as a systemic disease
  Ryan C, Banchereau R, Obermoser G, Lemoine B, Pascual V, Banchereau J, Chaussabel D, Menter A, J Invest Dermatol, 1/1/2010
• HLA-Cw*0602 as a predictor of response to TNF inhibitors in the treatment of chronic plaque psoriasis
  Ryan C, Kirby B, British Association of Dermatology Meeting, Glasgow, Scotland, 7/1/2009
• A study to examine if the HLACw* 0602 allele is a predictor of response to TNF-a inhibitors in the treatment of psoriasis
  Ryan C, Kelleher J, Collins P, Rogers S, Kirby B, Br J Dermatol, 1/1/2009
• Treatment of acrodermatitis continua of Hallopeau with adalimumab, Psoriasis Gene to Clinic
  Ryan C, Collins P, Kirby B, Rogers S, London, England, 12/1/2008
• Treatment of acrodermatitis continua of Hallopeau with adalimumab, Psoriasis Gene to Clinic
  Ryan C, Collins P, Kirby B, Rogers S, London, England, 12/1/2008
• Adalimumab Treatment for Severe Recalcitrant Psoriasis
  Ryan C, Kirby B, Collins P, Rogers S, British Association of Dermatology Meeting, Liverpool, England, 7/1/2008
• Treatment of acrodermatitis continua of Hallopeau with adalimumab
  Ryan C, Collins P, Kirby B, Rogers S, Br J Dermatol, 1/1/2008
• Two years' experience with adalimumab in severe, recalcitrant psoriasis
  Ryan C, Kirby B, Collins P, Rogers S, Br J Dermatol, 1/1/2008
• Growing Awareness and Changing Trends In Prevention Of Glucocorticoid-induced Osteoporosis, 2002-2006. A Re-audit
  Mohammad A, Ryan JG, Ralph N, Ryan C, O'Connell PG, Arth+Rheum, 1/1/2006
• Redefining outlook for survivors of class IV heart failure admission: Long term follow up of 536 patients in a hospital based disease management programme
  O'Loughlin C, Murphy N, Conlon C, Traynor T, Ryan C, Ledwidge M, McDonald K, Eur J Heart Fail, 1/1/2006
• Defining a new outlook for survivors of class IV heart failure admission: 3 year followup of 477 patients managed in a hospital based disease management program
  Conlon C, O'Loughlin C, Ryan C, Traynor C, Martos R, Ledwidge M, McDonald K, Eur J Heart Fail, 1/1/2005
• Diastolic and Systolic Heart failure patients derive similar benefit from a hospital based disease management program: 3 year follow up of 438 patients
  Martos R, Conlon C, O Loughlin C, Traynor C, Ryan C, Ledwidge M, Mc Donald K, Eur J Heart Fail, 1/1/2005
• Join now to see all

Lectures

• “The Shifting Paradigm in Psoriasis Treatment,” 
  International Psoriasis Council Meeting, Dallas, TX - 4/10/2014
• Research Gaps in Psoriasis: Genetics and Pathophysiology 
  Denver, CO - 3/1/2014
• TNF-alpha antagonists and p40 antibodies in psoriasis: similarities and differences 
  Stockholm, Sweden - 6/1/2012
• Psoriasis; what lies beneath 
  Dublin, Ireland - 5/1/2012
• Practical Case Management in Psoriasis 
  Dublin, Ireland - 5/1/2012
• The effect of biologic treatments on cardiovascular risk in psoriasis 
  Dallas, TX - 11/1/2011
• LEO 80185-G23 Guide to Clinical Assessments 
  San Antonio, TX - 9/1/2011
• The association between biologic treatments for psoriasis and cardiovascular risk 
  London, England - 7/1/2011
• Anti-IL-12/23 agents and JAK inhibitors for the treatment of psoriasis: a review 
  Dallas, TX - 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu... 
  Phoenix, AZ - 5/1/2011
• Clinical and genetic predictors of response to narrowband UVB in the treatment of chronic plaque psoriasis 
  Manchester, England - 7/1/2010
• A review of the safety profile of ustekinumab 
  Manchester, England - 7/1/2010
• The effect of narrowband ultraviolet B treatment for psoriasis on vitamin D status during wintertime in Ireland 
  Miami, FL - 3/1/2010
• Traditional systemic therapies for the treatment of psoriasis 
  Dallas, TX - 11/1/2009
• Anti-IL12/23 antibodies in the treatment of psoriasis/psoriatic arthritis 
  Dallas, TX - 11/1/2009
• CMV induced vasculopathy and perianal ulceration 
  San Francisco, CA - 3/1/2009
• Cryoglobulin associated angiomatosis 
  San Francisco, CA - 3/1/2009
• Updates in Psoriasis 
  Dublin, Ireland - 3/1/2009
• Adalimumab Treatment for Severe Recalcitrant Psoriasis 
  Dublin, Ireland - 4/1/2008
• Folliculotropic and Ichthyosiform Mycosis Fungoides 
  London, England - 12/1/2007
• Necrotising Lesions of the Male Genitalia 
  Dublin, Ireland - 9/1/2006
• Join now to see all